UK hair-loss shampoos: what one is legally allowed to claim

Start with the category, not the ingredient

Almost everything sold in the UK for thinning hair is a cosmetic. It holds no marketing authorisation, it has no licensed indication, and it is not a medicine in law. That is not a criticism; it is a classification, and it determines exactly what the bottle is allowed to tell you.

The Advertising Standards Authority's guidance for hair-loss advertising, published on 9 July 2026, draws the line. A claim that a product can "prevent, cure, or reverse hair loss or baldness" is likely to be seen as medicinal, and a medicinal claim requires MHRA authorisation. A non-medicinal claim — the example given is "reduces hair loss" — does not require authorisation, but it does require robust evidence.

So the first question at the shelf is not "does this work". It is "what is this actually claiming", because the answer tells you which regime the product has put itself inside.

Three kinds of sentence on a bottle

Cosmetic sentences describe appearance and feel: thicker-looking, fuller, adds body, reduces breakage. These are claims about how hair looks and behaves, they are perfectly legitimate, and they are not claims about hair loss. A product doing this honestly is doing something real and modest.

Borderline sentences describe a process: supports the scalp, maintains healthy growth, reduces shedding. The ASA's position is that these still need robust evidence, and that it assesses "the overall quality and relevance, not just volume" of what is offered. Advertisers commonly fail here, the guidance notes, by leaning on study abstracts, unrepresentative sample sizes and studies lacking control groups.

Medicinal sentences say the product treats, prevents, cures or reverses a condition. Without MHRA authorisation, that sentence should not be on a UK product at all.

Sorting a bottle into one of those three takes about ten seconds and is more informative than the ingredient list, because the ingredient list is not a claim and carries no evidential burden.

What the evidence conversation belongs to

This site's beat is UK rules rather than trial-grading, and the grading of shampoo actives — ketoconazole, caffeine, rosemary oil, peptides — is a large, genuinely contested literature that deserves more room than a UK-access page can give it. What can be said here is the UK-shaped part.

Two hair-loss products in this country hold marketing authorisations and have licensed indications you can read: the general-sale topical and the prescription tablet, set out in what is licensed for hair loss in the UK. A shampoo holds neither. That does not make a shampoo useless — an antifungal shampoo doing something useful for a scalp condition is doing a real job — but it does mean the two are not comparable objects, and a shelf that arranges them side by side is arranging them by aisle rather than by evidence.

Three conditions, not one

The ASA's guidance opens by distinguishing alopecia areata, which presents as patchy loss; chronic telogen effluvium, a temporary shedding; and androgenetic alopecia, pattern baldness. Its instruction to advertisers is not to over-generalise between them, because evidence gathered in one does not carry across to the others.

That distinction matters at the shelf as much as in an advertising file. A product marketed at "hair loss" is addressing three different processes with three different causes, and a shampoo that helps a flaking, inflamed scalp is doing something genuinely useful that has nothing to do with a receding hairline. Knowing which of the three you are dealing with changes which aisle is even relevant — and it is a question with a free answer, from a GP, rather than a question to be settled by reading bottles.

The cheapest honest answer

A generic ketoconazole shampoo bought from a UK pharmacy costs a few pounds, is widely available, and pays this site absolutely nothing. It is named here because it is the answer a lot of people are looking for when they arrive at an expensive scalp serum, and it would be dishonest to leave it out because there is no money in it.

The second free answer is the appointment. If the loss is sudden, patchy, follows a birth or an illness, or has no obvious explanation, a shampoo is not the question — those are the very situations the general-sale topical's own licence tells readers not to self-treat, and a GP can sort them out at no cost. What the NHS does and does not fund explains why that step is worth taking even when the NHS pays for none of the products.

One paid link, and what it is not

That is the whole commercial arrangement on this site, disclosed in full on how this site is paid. Everything else recommended here — the registers, the licences, a GP, a pharmacy's own shampoo — pays nothing.

How to read the shelf in a minute

1. Read the claim on the front, and sort it into cosmetic, borderline or medicinal.
2. If it is medicinal and the product is not a licensed medicine, put it down.
3. If evidence is invoked, look for a named study rather than the word "studies".
4. Check whether the product is addressing hair loss or hair appearance. Both are legitimate; only one is what you came for.
5. Compare the price against a generic pharmacy shampoo, which is the floor.
6. If the loss is sudden, patchy, or unexplained, stop shopping and book the free appointment.

None of those steps requires trusting this page, or any page. The rules are published by the ASA, the licences are published on the electronic medicines compendium, and the registers that matter for surgery are published by four regulators — the whole map of which is on hair transplants in the UK.